Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2014 Mar 7:6:36.
doi: 10.3389/fnagi.2014.00036. eCollection 2014.

The emerging role of nutrition in Parkinson's disease

Affiliations
Review

The emerging role of nutrition in Parkinson's disease

Stacey E Seidl et al. Front Aging Neurosci. .

Abstract

Parkinson's disease (PD) is the second most prevalent neurodegenerative disease in ageing individuals. It is now clear that genetic susceptibility and environmental factors play a role in disease etiology and progression. Because environmental factors are involved with the majority of the cases of PD, it is important to understand the role nutrition plays in both neuroprotection and neurodegeneration. Recent epidemiological studies have revealed the promise of some nutrients in reducing the risk of PD. In contrast, other nutrients may be involved with the etiology of neurodegeneration or exacerbate disease progression. This review summarizes the studies that have addressed these issues and describes in detail the nutrients and their putative mechanisms of action in PD.

Keywords: Parkinson's disease; antioxidants; neurodegeneration; neuroprotection; nutrition.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Role of nutrients in PD. Epidemiological and biochemical studies suggest that inclusion or exclusion of certain food groups may elicit neuroprotection or neurodegeneration. Foods are shown on a spectrum. Foods shown in the red promote neurodegeneration and foods in green promote neuroprotection. Foods shown in the middle (or yellow) part of the spectrum have conflicting results and need to be studied further to assess if they play a role in neurodegeneration or neuroprotection.

References

    1. Abbott R. D., Ross G. W., White L. R., Sanderson W. T., Burchfiel C. M., Kashon M., et al. (2003). Environmental, life-style, and physical precursors of clinical Parkinson's disease: recent findings from the Honolulu-Asia Aging Study. J. Neurol. 250Suppl. 3, III30–III39 10.1007/s00415-003-1306-7 - DOI - PubMed
    1. Aguiar L. M., Nobre H. V., Jr., Macedo D. S., Oliveira A. A., Freitas R. M., Vasconcelos S. M., et al. (2006). Neuroprotective effects of caffeine in the model of 6-hydroxydopamine lesion in rats. Pharmacol. Biochem. Behav. 84, 415–419 10.1016/j.pbb.2006.05.027 - DOI - PubMed
    1. Akbar M., Kim H. Y. (2002). Protective effects of docosahexaenoic acid in staurosporine-induced apoptosis: involvement of phosphatidylinositol-3 kinase pathway. J. Neurochem. 82, 655–665 10.1046/j.1471-4159.2002.01015.x - DOI - PubMed
    1. Alcalay R. N., Gu Y., Mejia-Santana H., Cote L., Marder K. S., Scarmeas N. (2012). The association between Mediterranean diet adherence and Parkinson's disease. Mov. Disord. 27, 771–774 10.1002/mds.24918 - DOI - PMC - PubMed
    1. Altman R. D., Lang A. E., Postuma R. B. (2011). Caffeine in Parkinson's disease: a pilot open-label, dose-escalation study. Mov. Disord. 26, 2427–2431 10.1002/mds.23873 - DOI - PubMed

LinkOut - more resources